Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis

Pruritus is the most common and burdensome symptom of atopic dermatitis (AD). Pruritus-targeted treatments in AD are lacking, particularly for patients with milder skin disease.

Source: Journal of Allergy and Clinical Immunology - July 13, 2023 Category: Allergy & Immunology Authors: Emma Guttman-Yassky, Paola Facheris, Joel Correa Da Rosa, Camille Rothenberg-Lausell, Ester del Duca, Eden David, Yeriel Estrada, Ying Liu, Swaroop Bose, Mashkura Chowdhury, Catherine Munera, Joana Goncalves, Kristine Nograles, Brian S. Kim, Mark Lebwohl Source Type: research